Novel mouse model for evaluating in vivo efficacy of xCT inhibitor
xCT, a well-known cystine transporter, is reported to be involved in the proliferation of various cells, such as cancer cells, immune cells, and fibroblasts. xCT inhibitor is expected to be a promising drug for cancer or immune diseases. However, there are little studies reporting that xCT inhibitor...
Saved in:
Main Authors: | Ryosuke Yoshioka (Author), Yusuke Fujieda (Author), Yamato Suzuki (Author), Osamu Kanno (Author), Asako Nagahira (Author), Tomohiro Honda (Author), Masao Murakawa (Author), Hiroshi Yukiura (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2019-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Decreased xCT activity in patients associated with Helicobacter pylori infection
by: Ling Wang, et al.
Published: (2022) -
Sulfasalazine Sensitizes Polyhematoporphyrin-Mediated Photodynamic Therapy in Cholangiocarcinoma by Targeting xCT
by: Yan-Wen Zheng, et al.
Published: (2021) -
A xCT role in tumour-associated ferroptosis shed light on novel therapeutic options
by: Daniela Criscuolo, et al.
Published: (2022) -
xCT-Driven Expression of GPX4 Determines Sensitivity of Breast Cancer Cells to Ferroptosis Inducers
by: Namgyu Lee, et al.
Published: (2021) -
A Negative Correlation Between Expression Profiles of Runt-Related Transcription Factor-2 and Cystine/Glutamate Antiporter xCT Subunit in Ovariectomized Mouse Bone
by: Kyosuke Uno, et al.
Published: (2011)